Revisiting TNM staging for EBV-related nasopharyngeal carcinoma
- PMID: 38402611
- DOI: 10.1016/j.ccell.2024.01.014
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma
Abstract
Advances in imaging and novel treatment approaches might have outpaced the prognostic capabilities of the current AJCC/UICC TNM 8th edition for staging nasopharyngeal carcinoma (NPC). In this issue of Cancer Cell, Du et al. propose a new TNM-9 classification that incorporates these updates.
Copyright © 2024. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.Cancer Cell. 2024 Mar 11;42(3):464-473.e3. doi: 10.1016/j.ccell.2023.12.020. Epub 2024 Jan 18. Cancer Cell. 2024. PMID: 38242125
-
Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.Cancer. 2019 Jan 1;125(1):79-89. doi: 10.1002/cncr.31741. Epub 2018 Oct 23. Cancer. 2019. PMID: 30351466
-
Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.Curr Oncol Rep. 2025 Mar;27(3):322-332. doi: 10.1007/s11912-025-01651-9. Epub 2025 Feb 25. Curr Oncol Rep. 2025. PMID: 39998781 Review.
-
Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.Eur Arch Otorhinolaryngol. 2014 Sep;271(9):2545-54. doi: 10.1007/s00405-013-2805-5. Epub 2013 Nov 9. Eur Arch Otorhinolaryngol. 2014. PMID: 24213277
-
Evolution of the Chinese staging system for nasopharyngeal carcinoma.Chin Clin Oncol. 2016 Apr;5(2):19. doi: 10.21037/cco.2016.03.04. Chin Clin Oncol. 2016. PMID: 27121879 Review.
Cited by
-
Intratumoral CD8+ tumor-infiltrating lymphocytes as prognostic predictors in radio-chemoradiotherapy-treated nasopharyngeal carcinoma.Front Oncol. 2025 May 15;15:1551980. doi: 10.3389/fonc.2025.1551980. eCollection 2025. Front Oncol. 2025. PMID: 40444078 Free PMC article.
-
Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.Cancer Manag Res. 2024 Sep 30;16:1321-1328. doi: 10.2147/CMAR.S481142. eCollection 2024. Cancer Manag Res. 2024. PMID: 39372707 Free PMC article.
-
FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.J Immunother Cancer. 2024 Nov 14;12(11):e010091. doi: 10.1136/jitc-2024-010091. J Immunother Cancer. 2024. PMID: 39542656 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources